Publicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (20)

2022

  1. Bioavailability of once-daily tacrolimus formulations used in clinical practice in the management of De Novo kidney transplant recipients: the better study

    Clinical transplantation, Vol. 36, Núm. 3, pp. e14550

  2. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  3. Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODA

    Nephrology Dialysis Transplantation, Vol. 37, Núm. 6, pp. 1140-1151

  4. Sex differences in COVID-19 mortality risk in patients on kidney function replacement therapy

    Scientific Reports, Vol. 12, Núm. 1

2021

  1. Clinical triage of patients on kidney replacement therapy presenting with COVID-19: An ERACODA registry analysis

    Nephrology Dialysis Transplantation, Vol. 36, Núm. 12, pp. 2308-2320

  2. Hemodialysis Centers Guide 2020

    Nefrologia, Vol. 41, pp. 1-77

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

  2. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration

    Nephrology Dialysis Transplantation, Vol. 35, Núm. 11, pp. 1973-1983

  3. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study

    Clinical Transplantation, Vol. 34, Núm. 1

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

  2. The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem

    Nefrologia

2018

  1. Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1

    American Journal of Kidney Diseases, Vol. 72, Núm. 3, pp. 411-418

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. Translational value of animal models of kidney failure

    European Journal of Pharmacology, Vol. 759, pp. 205-220

2014

  1. Impact of isolated hepatitis C virus (HCV) core-specific antibody detection and viral RNA amplification among HCV-seronegative dialysis patients at risk for infection

    Journal of Clinical Microbiology, Vol. 52, Núm. 8, pp. 3053-3056

2009

  1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function

    Clinical Transplantation, Vol. 23, Núm. 1, pp. 23-32

2008

  1. Benefits of preserving residual renal function in peritoneal dialysis

    Kidney International, Vol. 73, Núm. SUPPL. 108

2006

  1. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy - A Spanish multicentre experience

    Nephrology Dialysis Transplantation, Vol. 21, Núm. SUPPL. 2

2004

  1. Virus-Specific Effector CD4+ T-Cell Responses in Hemodialysis Patients with Hepatitis C Virus Infection

    Journal of Medical Virology, Vol. 72, Núm. 1, pp. 66-74